LEF blocks lymphocyte proliferation and hence the clonal expansion of autoreactive T cells in RA patients by inhibiting dihydroorotate dehydrogenase (DHODH), the mitochondrial rate-limiting enzyme in the de novo synthesis of pyrimidine ribonucleotides [4, 5]. Here, DHODH is linked to rheumatoid arthritis.